Papers/PMID:33347024
No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.
Journal of clinical psychopharmacology2020The record
1 finding drawn from this paper, on 1 compound across 1 endpoint.
What it reported
How to read these marksWhat moved
1 finding
coenzyme Q10 — increases circulating coenzyme Q10 concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“At 3 months, CoQ10 concentration was significantly higher in the CoQ10 group (3.85 μg/mL) compared with placebo (1.13 μg/mL); this difference was not present at 6 months.”
Quoted verbatim from No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.. - Study
- RCT
- Dose
- 300 mg/day
- Population
- adults with schizophrenia or schizoaffective disorder, CoQ10 300 mg/day vs placebo; measured at 3 months (difference not present at 6 months)